News/ Sales and Marketing/ US Amjevita, first Humira biosimilar approved – but no launch yet Andrew McConaghie Amgen, Amjevita, biosimilars, Humira 0 Comment Amgen’s biosimilar is ready to go, but AbbVie believes it can delay until 2022 Share X Amjevita, first Humira biosimilar approved – but no launch yet https://pharmaphorum.com/news/humira-biosimilar-approved/